Live Breaking News & Updates on Biopharmaceuticals

Stay updated with breaking news from Biopharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Exclusive | Made in China 2025: China meets most targets in manufacturing plan, proving US tariffs and sanctions ineffective

Almost 10 years after the ‘Made in China 2025’ targets were drawn up, we investigate just how many have been achieved. ....

France , Beidou , Anhui , China , Germany , Japan , United-states , Chinese , American , Joe-biden , Zang-jiyuan , Janet-yellen

CymaBay Therapeutics 4Q Loss/Shr 35c >CBAY

Please disregard the headline "Gilead Sciences Proposed to Acquire CymaBay for $32.50 Per Shr in Cash or a Total Equity Value of $4.3B," at 4:46 p.m. ET. The. ....

Gilead-sciences-proposed-to-acquire-cymabay , Sciences-proposed , Acquire-cymabay , Total-equity-value , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Synd , Cymabay-therapeutics

Viking Therapeutics offers new shares after stock soars

Viking Therapeutics has a stock offering starting at $85 a discount from its Wednesday closing price of $94.50. ....

Novo-nordisk-wegovy , Jason-mccarthy , Akash-tewaria , Lilly-mounjaro , Naz-rahman , Eli-lilly-co , Therapeutics-inc , Viking-therapeutics-inc , Eli-lilly , Novo-nordisk , Article-normal , Biotechnology